SXTP - 60 DEGREES PHARMACEUTICALS, INC.
2.3
-0.140 -6.087%
Share volume: 47,422
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$2.44
-0.14
-0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-14-2024 | 03-27-2025 | |
| Total revenue | 146.094 K | 125.700 K | 0.000 | 335.780 K | |
| Cost of revenue | 65.437 K | 89.564 K | 0.000 | 229.764 K | |
| Gross profit | 51.026 K | 35.408 K | 23.606 K | 112.769 K | |
| -30.61% | -33.33% | 377.71% | |||
| Operating expenses | 1.412 M | 4.225 M | 2.155 M | 2.219 M | |
| Selling general and admin | 1.075 M | 1.130 M | 1.215 M | 1.605 M | |
| Research and development | 337.182 K | 3.095 M | 940.063 K | 613.955 K | |
| Total expenses | 1.412 M | 4.205 M | 2.138 M | 2.256 M | |
| 197.75% | -49.15% | 5.47% | |||
| Operating income | -1.332 M | -4.189 M | -2.119 M | -2.076 M | |
| Ebit | 429.450 K | -4.190 M | -2.119 M | -2.068 M | |
| Pretax income | 428.048 K | -4.174 M | -2.160 M | -2.049 M | |
| -1,075.07% | -48.24% | -5.13% | |||
| Income tax | 63.000 | 438.000 | 250.000 | -501.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 427.985 K | -4.174 M | -2.160 M | -2.049 M | |
| -1,075.32% | 48.24% | 5.16% |
